Immunoassays in R&D Market Overview
Immunoassays are bioanalytical procedures in which the analyte's quantification is based on the reaction of an antigen (analyte) and an antibody. Immunoassays are widely utilized in pharmaceutical analysis, including illness diagnostics, therapeutic medication monitoring, clinical pharmacokinetics, and bioequivalence studies in drug development.
The major drivers propelling market expansion include factors such as the rising incidence rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advances.
On the other hand, the high cost of immunoassay procedures and the high cost of immunoassay systems limit the global market's growth.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Product & Service, Application, End User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Becton, Dickinson and Company, Danaher Corporation, bioMérieux Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corporation, and Abcam plc. |
Covid-19 Impact on Immunoassays in R&D Market
In addition, the current Immunoassays in R&D Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Immunoassays in R&D Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Immunoassays in R&D Market Segment Overview
According to Product & Service, the Kits and Reagents is one of the most prominent segments of the global Immunoassays in R&D Market. A reagent is an integral part of any chemical reaction. A reagent is a substance or compound that can facilitate a reaction, and they are used in the most widely used tests. This includes, for example, pregnancy tests, blood glucose tests, and most COVID-19 test kits.
Immunoassays in R&D Market, By Product & Service
· Kits and Reagents
· Analyzers
· Software and Services
Immunoassays in R&D Market, By Application
· Infectious Diseases
· Cancer Research
· Endocrinology
· Autoimmune Diseases
· Others
Immunoassays in R&D Market, By End User
· Pharmaceutical and Biotechnology Companies
· Academic Institutions and Laboratories
· Others
Immunoassays in R&D Regional Overview
The global Immunoassays in R&D market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the immunoassay in R&D market during the projected period. This is due to an increase in the number of research projects in laboratories, as research laboratories are critical to the regional market's growth. Government agencies also award a number of research grants. During the estimated period, the European market for immunoassays in R&D is predicted to be the second-largest. The regional market is likely to develop as their use in diagnostic measures increases. Asia-Pacific is expected to be the fastest-growing market. This is due to improved healthcare infrastructure and rising disposable income. The number of research activities in the region has expanded as the healthcare infrastructure has improved. Other factors likely to enhance regional market growth include an increase in the number of research and development centers and a focus on strategic collaborations by companies operating in the market.
Immunoassays in R&D Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Immunoassays in R&D Market Competitor overview
Some key developments and strategies adopted by manufacturers in Anti-Reflective Coatings are highlighted below.
· In May 2018, Bio-Rad Laboratories Inc. announced the launch of StarBright Blue 520 Fluorescent Secondary Antibodies, fluorescent dye-labeled secondary antibodies for use in multiplex western blotting. They exhibit a two- to the threefold lower limit of detection than traditional green emission fluorophore-labeled antibodies such as Alexa Fluor 488 or DyLight 488, the current industry standards.
Immunoassays in R&D Market, Key Players
· Bio-Rad Laboratories, Inc.
· Thermo Fisher Scientific Inc.
· Siemens Healthineers
· Becton
· Dickinson and Company
· Danaher Corporation
· bioMérieux Inc.
· Abbott Laboratories
· F. Hoffmann-La Roche Ltd
· Sysmex Corporation
· Abcam plc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Immunoassays in R&D market?
The major drivers propelling market expansion include factors such as the rising incidence rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advances
Q2. What are the restraining factors for the global Immunoassays in R&D market?
The high cost of immunoassay procedures and the high cost of immunoassay systems limit the global market's growth
Q3. Which segment is projected to hold the largest share in the global Immunoassays in R&D market?
Kits and Reagents segment is projected to hold the largest share in the global Immunoassays in R&D market.
Q4. Which region holds the largest share in the global Immunoassays in R&D market?
North America holds the largest share in the global Immunoassays in R&D market
Q5. Which are the prominent players in the global Immunoassays in R&D market?
Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Becton, Dickinson and Company, Danaher Corporation, bioMérieux Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corporation, and Abcam plc. are some key players in the global Immunoassays in R&D market
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product & Service
- 5.2.1. Kits and Reagents
- 5.2.2. Analyzers
- 5.2.3. Software and Services
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Infectious Diseases
- 5.3.2. Cancer Research
- 5.3.3. Endocrinology
- 5.3.4. Autoimmune Diseases
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Pharmaceutical and Biotechnology Companies
- 5.4.2. Academic Institutions and Laboratories
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product & Service
- 6.2.1. Kits and Reagents
- 6.2.2. Analyzers
- 6.2.3. Software and Services
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Infectious Diseases
- 6.3.2. Cancer Research
- 6.3.3. Endocrinology
- 6.3.4. Autoimmune Diseases
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Pharmaceutical and Biotechnology Companies
- 6.4.2. Academic Institutions and Laboratories
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product & Service
- 7.2.1. Kits and Reagents
- 7.2.2. Analyzers
- 7.2.3. Software and Services
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Infectious Diseases
- 7.3.2. Cancer Research
- 7.3.3. Endocrinology
- 7.3.4. Autoimmune Diseases
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Pharmaceutical and Biotechnology Companies
- 7.4.2. Academic Institutions and Laboratories
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product & Service
- 8.2.1. Kits and Reagents
- 8.2.2. Analyzers
- 8.2.3. Software and Services
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Infectious Diseases
- 8.3.2. Cancer Research
- 8.3.3. Endocrinology
- 8.3.4. Autoimmune Diseases
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Pharmaceutical and Biotechnology Companies
- 8.4.2. Academic Institutions and Laboratories
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product & Service
- 9.2.1. Kits and Reagents
- 9.2.2. Analyzers
- 9.2.3. Software and Services
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Infectious Diseases
- 9.3.2. Cancer Research
- 9.3.3. Endocrinology
- 9.3.4. Autoimmune Diseases
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Pharmaceutical and Biotechnology Companies
- 9.4.2. Academic Institutions and Laboratories
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Bio-Rad Laboratories, Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Thermo Fisher Scientific Inc.
- 10.6. Siemens Healthineers
- 10.7. Becton
- 10.8. Dickinson and Company
- 10.9. Danaher Corporation
- 10.10. bioMérieux Inc.
- 10.11. Abbott Laboratories
- 10.12. F. Hoffmann-La Roche Ltd
- 10.13. Sysmex Corporation
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
